Evidence map›Paper›PMID 31554611›Full record

ArticleBMJ (Clinical research ed.)2019

Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study.

Yahia Al-Jebari, Angel Elenkov, Elin Wirestrand, Indra Schütz, Aleksander Giwercman, Yvonne Lundberg Giwercman

Open access · hybridAbstract readComparative Study
In one paragraph

Article in BMJ (Clinical research ed.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Male Fertility as a Proxy for Health.Journal of clinical medicine · 2024
    Review
  13. Interplay between male gonadal function and overall male health.Journal of basic and clinical physiology and pharmacology · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Yahia Al-JebariDepartment of Translational Medicine, Lund University, Malmö, Sweden yahia.al-jebari@med.lu.se.ORCID https://orcid.org/0000-0002-2474-0471
Angel ElenkovDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Elin WirestrandDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Indra SchützDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Aleksander GiwercmanDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Yvonne Lundberg GiwercmanDepartment of Translational Medicine, Lund University, Malmö, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the risk and severity of prostate cancer between men achieving fatherhood by assisted reproduction and men conceiving naturally.

designNational register based cohort study.

settingSweden from January 1994 to December 2014.

participants1 181 490 children born alive in Sweden during 1994-2014 to the same number of fathers. Fathers were grouped according to fertility status by mode of conception: 20 618 by in vitro fertilisation (IVF), 14 882 by intra-cytoplasmic sperm injection (ICSI), and 1 145 990 by natural conception.

main outcome measuresProstate cancer diagnosis, age of onset, and androgen deprivation therapy (serving as proxy for advanced or metastatic malignancy).

resultsAmong men achieving fatherhood by IVF, by ICSI, and by non-assisted means, 77 (0.37%), 63 (0.42%), and 3244 (0.28%), respectively, were diagnosed as having prostate cancer. Mean age at onset was 55.9, 55.1, and 57.1 years, respectively. Men who became fathers through assisted reproduction had a statistically significantly increased risk of prostate cancer compared with men who conceived naturally (hazard ratio 1.64, 95% confidence interval 1.25 to 2.15, for ICSI; 1.33, 1.06 to 1.66, for IVF). They also had an increased risk of early onset disease (that is, diagnosis before age 55 years) (hazard ratio 1.86, 1.25 to 2.77, for ICSI; 1.51, 1.09 to 2.08, for IVF). Fathers who conceived through ICSI and developed prostate cancer received androgen deprivation therapy to at least the same extent as the reference group (odds ratio 1.91; P=0.07).

conclusionsMen who achieved fatherhood through assisted reproduction techniques, particularly through ICSI, are at increased risk for early onset prostate cancer and thus constitute a risk group in which testing and careful long term follow-up for prostate cancer may be beneficial.

Indexed as

AdultAge of OnsetAndrogen AntagonistsCohort StudiesFertilizationFertilization in VitroHumansInfertility, MaleMaleMiddle AgedProstatic NeoplasmsRegistriesRisk FactorsSperm Injections, IntracytoplasmicSurvival AnalysisSwedenAndrogen Antagonists

Identifiers

PMID31554611
PMCPMC6759809
OpenAlexW2976993994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.